Vero-Vincristine

Vero-Vincristine: An effective cytostatic agent for the fight against cancer

Vero-Vincristine is a pharmaceutical drug used in oncology to treat various types of malignant tumors. It belongs to the group of alkaloids and other cytostatic drugs of plant origin and is produced in Russia by Veropharm, Belgorod, Okasa Pharma and Lance-Pharm.

Vero-Vincristine has the international name "Vinkristine" and is widely known under various synonyms, such as Vincristine sulfate, Vincristine-LENS, Vincristine-Richter, Vincristine-Teva, Vincristine sulfate, Oncocristine, Cytocristine and Cytomide.

The dosage form of Vero-Vincristine is available in several versions, including solution for injection, solution for intravenous administration and lyophilized powder for the preparation of injection solution. Drug concentrations are 1 mg/ml and 0.5 mg/ml.

The active substance of Vero-Vincristine is Vincristine. This component has cytotoxic properties and is able to suppress the growth and reproduction of cancer cells. The drug is widely used in the treatment of acute lymphoblastic leukemia, lymphogranulomatosis, non-Hodgkin's lymphoma, rhabdomyosarcoma, bone and soft tissue sarcoma, Ewing's sarcoma, neuroblastoma, Wilms tumor, breast cancer, epithelioma, small cell lung cancer, idiopathic thrombocytopenic purpura and other types of tumors.

However, Vero-Vincristine has a number of contraindications. Its use is undesirable in case of hypersensitivity to the drug, bone marrow hypoplasia, diseases of the nervous system, as well as during pregnancy and lactation.

When using Vero-Vincristine, side effects are possible, such as abdominal pain, nausea, paralytic ileus, neuropathy, loss of some types of sensitivity and tendon reflexes, severe paresthesia, jaw pain, ataxia, decreased muscle strength, damage to the cranial nerves, alopecia, moderate leukopenia, thrombocytopenia, impaired secretion of antidiureticsVero-Vincristine is an effective cytostatic drug that is used to treat various types of cancer. Its active substance, Vincristine, has the ability to suppress the growth and reproduction of cancer cells. The drug is used in the treatment of acute lymphoblastic leukemia, lymphogranulomatosis, non-Hodgkin's lymphoma, sarcoma, breast cancer, lung cancer and other tumors.

Vero-Vincristine is available in various dosage forms, including solution for injection and powder for injection. Its use is carried out under the supervision of a physician, usually in a hospital setting.

Like all medicines, Vero-Vincristine may cause side effects. Some of these include abdominal pain, nausea, bowel dysfunction, neuropathy, sensory loss, jaw pain, ataxia, alopecia, leukopenia and thrombocytopenia. Side effects can vary in severity, and their occurrence and severity may vary between patients.

It is important to note that Vero-Vincristine has contraindications and limitations in use. Before starting treatment, you should consult your doctor and inform him about all existing diseases, medications you are taking and other factors that may affect the safety and effectiveness of the drug.

Vero-Vincristine is a strong anti-tumor agent and should only be used under the supervision of an experienced healthcare professional.